Insurance

71 tickers in this theme
Ranks this page's recent reports by score.
Loews Corporation
L·Financials
A ★★★★Buy
Current$116.01
Target$134.00
Return+15.5%
Aug 5, 2026

Loews offers a compelling sum-of-the-parts discount, driven by strong underwriting momentum at CNA Financial and massive share repurchases funded by robust subsidiary dividends, outweighing localized risks in hospitality and pipeline operations.

Score
91
NMI Holdings, Inc.
NMIH·Financials
A ★★★★Buy
Current$44.30
Target$48.00
Return+8.4%
Aug 4, 2026

NMI Holdings couples structurally superior underwriting margins and aggressive buybacks to compound value, though investors must stomach inherent exposure to U.S. housing and employment macro cycles.

Score
88
KKR & Co. Inc.
KKR·Financials
S ★★★★★Strong Buy
Current$101.43
Target$139.14
Return+37.2%
Aug 3, 2026

KKR's structural transformation into a permanent-capital powerhouse via Global Atlantic guarantees massive, compounding fee growth, though its balance sheet remains sensitive to severe credit default cycles.

Score
97
Willis Towers Watson Public Limited Company
WTW·Financials
S ★★★★★Strong Buy
Current$335.92
Target$400.00
Return+19.1%
Aug 3, 2026

Willis Towers Watson combines deeply discounted, oligopolistic free cash flow generation with a massive $400 million AI-driven margin expansion catalyst, though cyclical softening in P&C insurance pricing poses a modest near-term headwind to top-line commission growth.

Score
97
Arthur J. Gallagher & Co.
AJG·Financials
B ★★★Hold
Current$249.42
Target$287.00
Return+15.1%
Aug 2, 2026

An elite, inflation-protected compounding machine with unassailable scale, currently fairly priced to perfectly execute the largest M&A integration in its history.

Score
79
Markel Group Inc.
MKL·Financials
B ★★★Hold
Current$1,886.16
Target$2,383.00
Return+26.3%
Aug 2, 2026

Markel is a profoundly undervalued compounding machine generating massive float, but it requires extreme patience as investors wait for management to resolve severe counterparty credit risks and structural activist battles.

Score
80
Aon plc
AON·Financials
B ★★★Hold
Current$360.55
Target$393.11
Return+9.0%
Aug 1, 2026

An oligopolistic risk brokerage platform armed with overwhelming data and switching costs is structurally expanding EPS via restructuring and massive buybacks, but short-term rate cut pressures and NFP debt indigestion cap valuation upside.

Score
81
Everest Group, Ltd.
EG·Financials
B ★★★Hold
Current$398.70
Target$440.00
Return+10.4%
Jul 30, 2026

Everest Group pairs an exceptionally cheap 7.4x forward P/E and thriving property catastrophe reinsurance lines with lingering apprehension over historical U.S. casualty reserve deterioration, making its ongoing strategic restructuring the pivotal factor for long-term rerating.

Score
79
W. R. Berkley Corporation
WRB·Financials
B ★★★Hold
Current$75.46
Target$85.00
Return+12.6%
Jul 30, 2026

W. R. Berkley offers elite, moat-protected ROE compounding driven by decentralized underwriting and massive buybacks, but aggressive relative valuation and emerging reserve adequacy risks command a cautious stance.

Score
75
Principal Financial Group, Inc.
PFG·Financials
A ★★★★Buy
Current$114.09
Target$128.87
Return+12.9%
Jul 30, 2026

Principal Financial is a highly profitable, capital-light compounder dominating the SMB retirement ecosystem with powerful SECURE 2.0 tailwinds, though it faces persistent psychological overhangs from its commercial real estate mortgage portfolio.

Score
89
AXIS Capital Holdings Limited
AXS·Financials
A ★★★★Buy
Current$119.27
Target$135.00
Return+13.2%
Jul 30, 2026

AXIS Capital represents a deeply undervalued, brilliantly de-risked specialty insurance compounder supported by aggressive share buybacks, but near-term upside is heavily constrained by cyclical rate softening and severe property catastrophe volatility.

Score
88
Unum Group
UNM·Financials
A ★★★★Buy
Current$86.22
Target$100.62
Return+16.7%
Jul 29, 2026

Unum offers immense value through expanding core margins and aggressive share buybacks, provided its ongoing reinsurance strategy successfully caps the residual tail risk of its legacy long-term care block.

Score
87
Old Republic International Corporation
ORI·Financials
B ★★★Hold
Current$42.29
Target$46.37
Return+9.6%
Jul 28, 2026

Old Republic offers an unassailable balance sheet and elite capital returns, but near-term upside is constrained by deteriorating commercial P&C underwriting margins and a frozen real estate market.

Score
75
Arch Capital Group Ltd.
ACGL·Financials
B ★★★Hold
Current$103.36
Target$120.00
Return+16.1%
Jul 28, 2026

Arch Capital is a best-in-class compounder buffered by an ultra-profitable mortgage segment and a massive $3B buyback floor, though near-term top-line growth will be muted as management expertly shrinks its reinsurance book to avoid the current soft pricing cycle.

Score
84
RenaissanceRe Holdings Ltd.
RNR·Financials
A ★★★★Buy
Current$329.10
Target$390.00
Return+18.5%
Jul 28, 2026

RenaissanceRe pairs an elite, moat-protected underwriting engine and surging fee income with massive share repurchases, though its inherent exposure to binary climate catastrophes demands a permanent risk discount.

Score
86
Brown & Brown, Inc.
BRO·Financials
B ★★★Hold
Current$67.66
Target$75.00
Return+10.8%
Jul 27, 2026

The compelling 15.1x forward valuation and relentless free cash flow generation are currently neutralized by stalling organic growth, massive equity dilution, and the high-wire execution risk of integrating 5,000 new employees.

Score
75
Cincinnati Financial Corporation
CINF·Financials
B ★★★Hold
Current$182.81
Target$196.00
Return+7.2%
Jul 27, 2026

Cincinnati Financial is a uniquely structured, agency-driven P&C compounder with a fortress balance sheet and a 65-year dividend streak, but its current valuation premium limits near-term upside.

Score
81
Globe Life Inc.
GL·Financials
B ★★★Hold
Current$173.48
Target$195.00
Return+12.4%
Jul 27, 2026

Globe Life offers a highly profitable, cash-generative insurance model with an incredibly durable ROE, but near-term health margin compression and heavy insider selling warrant a neutral stance.

Score
80
The Hartford Insurance Group, Inc.
HIG·Financials
S ★★★★★Strong Buy
Current$140.53
Target$165.00
Return+17.4%
Jul 26, 2026

The Hartford offers an irresistible combination of elite commercial underwriting profitability and a relentless $4.2 billion share cannibalization engine, though investors must monitor the creeping threat of social inflation on its general liability reserves.

Score
97
Chubb Limited
CB·Financials
S ★★★★★Strong Buy
Current$343.23
Target$395.00
Return+15.1%
Jul 25, 2026

Chubb perfectly pairs elite underwriting discipline (83.8% combined ratio) with massive capital returns, though cyclical softening in commercial property markets demands close monitoring.

Score
96
Marsh & McLennan Companies, Inc.
MRSH·Financials
A ★★★★Buy
Current$176.40
Target$214.70
Return+21.7%
Jul 25, 2026

Marsh McLennan's unparalleled scale and proprietary risk data ensure secular margin expansion, though near-term debt loads and softening commercial insurance pricing demand disciplined management execution.

Score
90
The Progressive Corporation
PGR·Financials
S ★★★★★Strong Buy
Current$207.95
Target$254.20
Return+22.2%
Jul 22, 2026

Progressive pairs an unbreachable telematics moat with industry-leading underwriting margins to compound capital at 30%+ ROE, rendering its valuation severely undervalued despite cyclical inflation risks.

Score
95
The Travelers Companies, Inc.
TRV·Financials
S ★★★★★Strong Buy
Current$368.98
Target$430.00
Return+16.5%
Jul 21, 2026

Travelers combines a pristine 83.6% combined ratio with elite capital returns, yet the market erroneously discounts it at a single-digit P/E over unwarranted climate and cycle fears.

Score
100